Chronic Myelogenous Leukemia Medications
Drugs (by generic name) associated with Chronic Myelogenous Leukemia
The following drugs and medications are in some way related to, or used in the treatment of Chronic Myelogenous Leukemia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Chronic Myelogenous Leukemia Medications in the Pipeline
- November 10, 2009 - ChemGenex Announces FDA Accepts NDA for Omapro (Omacetaxine Mepesuccinate) and Grants the Filing Priority Review Status
- September 9, 2009 - ChemGenex Submits New Drug Application for Omapro (omacetaxine Mepesuccinate) to U.S. FDA
- July 1, 2008 - ChemGenex Announces Submission of Non-Clinical Section of Rolling NDA for Omacetaxine
- April 14, 2008 - ChemGenex appoints VP Regulatory Affairs - Confirms Planned NDA Rolling Submission for Omacetaxine Following Meeting with U.S. FDA
Latest Chronic Myelogenous Leukemia Blog Post
ChemGenex's Omacetaxine Kills Leukemic Stem Cells in Human CML Models
New In Vitro Research with Omacetaxine in Human Cancer Stem Cells May Point to a Future Approach to Treating CML
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 8, 2009 - ChemGenex Pharmaceuticals Limited (ASX:CXS), announced today that...
View all Chronic Myelogenous Leukemia blog posts.
Chronic Myelogenous Leukemia Support Group Questions
Go to the Chronic Myelogenous Leukemia support group or view all Chronic Myelogenous Leukemia questions.
Ask a Question about Chronic Myelogenous Leukemia:
Learn more about Chronic Myelogenous Leukemia
Medical encyclopedia results for:
